|
|
Vaccine Detail
|
Autologous tumor cell lysate vaccine |
| Vaccine Information |
- Vaccine Name: Autologous tumor cell lysate vaccine
- Target Pathogen: Cancer
- Target Disease: Cancer
- Type: whole cell cancer vaccine
- Status: Clinical trial
- Host Species for Licensed Use: None
- Immunization Route: subcutaneous injection
- Description: Vaccines made from the patient's cancer cells may make the body build an immune response and kill their tumor cells. The autologous tumor cell vaccine will be given together with adjuvant interferon gamma or sargramostim (GM-CSF) in patients with advanced cancer (breast, lung, prostate, colorectal, sarcoma, renal, melanoma). The vaccine uses irradiated autologous tumor cells and tumor lysate. (NCT00002505)
|
| Host Response |
|
|
| References |
NCT00002505: Tumor Cell Vaccine in Treating Patients With Advanced Cancer [https://clinicaltrials.gov/study/NCT00002505]
|
|
